Skip to content

COMPARING TWO METHODS TO IMPROVE VISION AFTER CATARACT SURGERY IN SMALL EYES : TRADITIONAL VS AI BASED KANE FORMULA

VISUAL AND REFRACTIVE OUTCOME OF INTRAOCULAR LENS CALCULATION IN SHORT EYES: HOFFER-Q VERSUS AI BASED KANE FORMULA A COMAPARATIVE STUDY : RANDOMISED CONTROL TRIAL - VISION SAFE Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093070
Enrollment
60
Registered
2025-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Kane formula: It combines theoretical optics with modern data science techniques, including artificial intelligence. Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention

Sponsors

PriyankaPadarthi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults undergoing uneventful SICS with posterior chamber intraocular lens (IOL) implantation. Axial length less than 22.0 mm as measured by A-scan biometry. Willingness to participate and attend follow-up visits.

Exclusion criteria

Exclusion criteria: Prior ocular surgery or trauma. Intraoperative or postoperative complications. Eyes with corneal opacities or irregular astigmatism.. Patients who have undergone refractive & retinal surgeries.

Design outcomes

Primary

MeasureTime frame
To compare the post operative refractive error accuracy of the Hoffer Q and Kane formulas in short eyes.Timepoint: At the time of discharge at day 1 postoperatively At 1 week postoperatively At 4 weeks postoperatively

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactPriyanka Padarthi

mahatma gandhi medical college and research institute

kskanth99@rediffmail.com7396859070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026